Home
Storia in 1 fonti
US FTC imposes divestment condition on Aurobindo Pharma's $250 mn Lannett acquisition
The U.S. Federal Trade Commission (FTC) has mandated that Aurobindo Pharma must sell off four specific drug products. This action is a condition for Aurobindo Pharma to finalize its acquisition of Lannett Company Inc., ensuring no anti-competitive issues arise from the deal.
Raccontata da
economictimes.indiatimes.com
Timeline cronologica
- ·
US FTC imposes divestment condition on Aurobindo Pharma's $250 mn Lannett acquisition
The U.S. Federal Trade Commission (FTC) has mandated that Aurobindo Pharma must sell off four specific drug products. This action is a condition for Aurobindo Pharma to finalize…
- ·
Aurobindo Pharma clears key US hurdle in Lannett acquisition, closing expected soon
Indian drug giant Aurobindo Pharma is set for a major US expansion. The company has received crucial antitrust clearance from the US Federal Trade Commission for its takeover of…